tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RARE Stock Latest News

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesUltragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18h ago
RARE
3 Best Stocks to Buy Now, 4/17/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 4/17/2024, According to Top Analysts 
3d ago
RCL
UAL
Ultragenyx announces results from interim Phase 1/2 data of GTX-102
PremiumThe Fly
Ultragenyx announces results from interim Phase 1/2 data of GTX-102
5d ago
RARE
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
PremiumPress Releases
Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
8d ago
RARE
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
PremiumPress Releases
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
8d ago
RARE
Ultragenyx participates in a conference call hosted by Cantor Fitzgerald
PremiumThe FlyUltragenyx participates in a conference call hosted by Cantor Fitzgerald
16d ago
RARE
Ultragenyx participates in a conference call hosted by Cantor Fitzgerald
PremiumThe Fly
Ultragenyx participates in a conference call hosted by Cantor Fitzgerald
16d ago
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29d ago
RARE
JPMorgan ups Ultragenyx target, opens ‘Positive Catalyst Watch’ into data
PremiumThe Fly
JPMorgan ups Ultragenyx target, opens ‘Positive Catalyst Watch’ into data
1M ago
RARE
3 Best Stocks to Buy Now, 3/15/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 3/15/2024, According to Top Analysts 
1M ago
APLD
PRQR
Ultragenyx to Participate at Investor Conferences in March
PremiumPress Releases
Ultragenyx to Participate at Investor Conferences in March
2M ago
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2M ago
RARE
Ultragenyx price target raised to $111 from $110 at TD Cowen
PremiumThe FlyUltragenyx price target raised to $111 from $110 at TD Cowen
2M ago
RARE
Ultragenyx price target raised to $48 from $47 at Wedbush
PremiumThe Fly
Ultragenyx price target raised to $48 from $47 at Wedbush
2M ago
RARE
Ultragenyx sees FY24 revenue $500M-$530M, consensus $504.31M
PremiumThe Fly
Ultragenyx sees FY24 revenue $500M-$530M, consensus $504.31M
2M ago
RARE
Ultragenyx reports Q4 EPS ($1.52), consensus ($1.62)
PremiumThe Fly
Ultragenyx reports Q4 EPS ($1.52), consensus ($1.62)
2M ago
RARE
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
PremiumPress Releases
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
2M ago
RARE
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RARE
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update
PremiumPress Releases
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update
2M ago
RARE
Ultragenyx announces data demonstrating treatment with UX111
PremiumThe FlyUltragenyx announces data demonstrating treatment with UX111
2M ago
RARE
Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Heparan Sulfate Exposure in Cerebrospinal Fluid Correlated with Improved Long-term Cognitive Function in Patients with Sanfilippo Syndrome Type A (MPS IIIA)
PremiumPress Releases
Ultragenyx Announces Data Demonstrating Treatment with UX111 Results in Significant Reduction in Heparan Sulfate Exposure in Cerebrospinal Fluid Correlated with Improved Long-term Cognitive Function in Patients with Sanfilippo Syndrome Type A (MPS IIIA)
2M ago
RARE
Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treatment of Angelman Syndrome
PremiumPress Releases
Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treatment of Angelman Syndrome
2M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >